| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |